Effect of baicalin on inflammatory response and TLR4/NF-κB signaling pathway of human brain microvascular endothelial cell after hypoxia-reoxygenation injury

ZHANG Ye-hao1 MIAO Lan1 ZHANG Peng1 LIU Guang-yu1 LIU Jian-xun1

(1.Beijing Key Laboratory of Pharmacology of Chinese Materia Region, Institute of Basic Medical Sciences, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China 100091)
【Knowledge Link】sentinel cell

【Abstract】In this study, the oxygen-glucose deprivation (OGD) model in the human brain microvascular endothelial cells (HBMECs) was used to simulate the ischemic neuronal damage, observe the inflammatory response, and explore the possible mechanisms for treating cerebral ischemia/reperfusion and improving memory impairment from the view point of inhibiting inflammatory response, which is of great reference significance for related Chinese medicine treatment of ischemic diseases. HBMECs were given with drugs at the same time of OGD injury, and reoxygenated for 2 h after treatment for 4 h. Cell supernatant was then collected, and the inflammatory factors in cell supernatant were detected. Immunofluorescence assay was used to detect HBMEC morphology and expression of p-nuclear factor kappa-light-chain-enhancer of activated B (p-NF-κB); Western blot was used to detect expression changes of Toll-like receptor 4 (TLR4), myeloid differentiation primary response 88 (MYD88) and p-NF-κB. The results showed that, after OGD modeling, the levels of interleukin 6 (IL-6), IL-1α, IL-1β and tumor necrosis factor-α (TNF-α) were significantly increased; baicalin protected HBMECs, inhibited intranuclear transcription of p-NF-κB, significantly decreased HBMEC release of inflammatory factors caused by OGD injury, and inhibited the expression of TLR4, MYD88, and p-NF-κB. The studies suggested that baicalin had obvious protective effect on HBMECs damaged by OGD, and could inhibit inflammatory response. Its protection mechanism may be related to inhibiting TLR4 signaling pathways.

【Keywords】 baicalin; human brain microvascular endothelial cell (HBMEC); cytokines; oxygen-glucose deprivation (OGD); TLR4; NF-κB;


【Funds】 Independent Research Project of China Academy of Chinese Medical Sciences (ZZ11-068) National Natural Science Foundation of China (81903841)

Download this article


    [1] GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 [J]. Lancet Neurol, 2019, 18 (5): 459.

    [2] ELKIND M S, CHENG J, RUNDEK T, et al. Leukocyte count predicts outcome after ischemic stroke: the Northern Manhattan Stroke Study [J]. J Stroke Cerebrovasc Dis, 2004, 13 (5): 220.

    [3] MAIUOLO J, GLIOZZI M, MUSOLINO V, et al. The role of endothelial dysfunction in peripheral blood nerve barrier: molecular mechanisms and pathophysiological implications [J]. Int J Mol Sci, 2019, 20 (12): 3022.

    [4] ZLOKOVIC B V. Neurovascular pathways to neurodegeneration in Alzheimer′s disease and other disorders [J]. Nat Rev Neurosci, 2011, 12 (6): 723.

    [5] LI L, LIU M, HE L, et al. Baicalin relieves TNF-α-evoked injury in human aortic endothelial cells by up-regulation of miR-145 [J]. Phytother Res, 2020, 34 (4): 836.

    [6] JI W, LIANG K, AN R, et al. Baicalin protects against ethanol-induced chronic gastritis in rats by inhibiting Akt/NF-κB pathway [J]. Life Sci, 2019, 239: 117064.

    [7] YAN G, WANG J, YI T, et al. Baicalin prevents pulmonary arterial remodeling in vivo via the AKT/ERK/NF-κB signaling pathways [J]. Pulm Circ, 2019, doi: 10.1177/2045894019878599.

    [8] WANG W, ZHENG J, CUI N, et al. Baicalin ameliorates polycystic ovary syndrome through AMP-activated protein kinase [J]. J Ovarian Res, 2019, 12 (1): 109.

    [9] WU Y, SONG X, KEBEBE D, et al. Brain targeting of baicalin and salvianolic acid B combination by OX26 functionalized nanostructured lipid carriers [J]. Int J Pharm, 2019, 571: 118754.

    [10] ZHOU H C, DU R, WANG H, et al. Advance in studies on pharmacokinetics of baicalin [J]. China Journal of Chinese Materia Medica, 2018, 43 (4): 684 (in Chinese).

    [11] ZHOU R Y, MA B X, HAN X M, et al. Effect of baicalin on growth state of attention deficit hyperactivity disorder animal model and its regulation on Ca MKⅡ and ERK1/2 [J]. China Journal of Chinese Materia Medica, 2019, 44 (6): 1220 (in Chinese).

    [12] WANG J K, WANG L C, JIANG Y, et al. Neuroprotective effects and mechanism of ethanol extract of Cistanche tubulosa against oxygen-glucose deprivation/reperfusion [J]. China Journal of Chinese Materia Medica, 2019, 44 (13): 2686 (in Chinese).

    [13] SWEET D R, FAN L, HSIEH P N, et al. Krüppel-like factors in vascular inflammation:mechanistic insights and therapeutic potential [J]. Front Cardiovasc Med, 2018, 5: 6.

    [14] LEY K, LAUDANNA C, CYBULSKY M I, et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated [J]. Nat Rev Immunol, 2007, 7 (9): 678.

    [15] DEL ZOPPO G J. Inflammation and the neurovascular unit in the setting of focal cerebral ischemia [J]. Neuroscience, 2009, 158 (3): 972.

    [16] MORRISON B M, TSINGALIA A, VIDENSKY S, et al. Deficiency in monocarboxylate transporter 1 (MCT1) in mice delays regeneration of peripheral nerves following sciatic nerve crush [J]. Exp Neurol, 2015, 263: 325.

    [17] JAIMES L, VINET R, KNOX M, et al. A review of the actions of endogenous and exogenous vasoactive substances during the estrous cycle and pregnancy in rats [J]. Animals, 2019, 9 (6): 288.

    [18] TU X K, YANG W Z, SHI S S, et al. Inhibitory effect of baicalin on the expression of TNF-α and AQP-4 and the brain damage following cerebral ischemia in rats [J]. Chinese Pharmacological Bulletin, 2013, 29 (9): 1222 (in Chinese).

This Article


CN: 11-2272/R

Vol 45, No. 19, Pages 4686-4691

October 2020


Article Outline



  • 1 Materials
  • 2 Methods
  • 3 Results
  • 4 Discussion
  • References